Get Premium to unlock powerful stock data
CASI Pharmaceuticals Inc logo

CASI Pharmaceuticals Inc

$ 0.37 +0.0075 (+2.07%) 10:08 PM EST
P/E:
At Loss
P/B:
0.67
Market Cap:
$ 50.34M
Enterprise V:
$ 14.74M
Volume:
125.07K
Avg Vol (2M):
333.81K
Also Trade In:
Volume:
125.07K
Market Cap $:
50.34M
PE Ratio:
At Loss
Avg Vol (2-Month):
333.81K
Enterprise Value $:
14.74M
PB Ratio:
0.67
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

CASI Pharmaceuticals Inc
NAICS : 325412 SIC : 2836
9620 Medical Center Drive, Suite 300, Rockville, MD, USA, 20850
Description
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing innovative therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA. The company primarily operates in the United States, Canada, China and other parts of the world.
Name Current Vs Industry Vs History
Cash-To-Debt 19.91
Equity-to-Asset 0.58
Debt-to-Equity 0.03
Debt-to-EBITDA -0.06
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -6.24
Distress
Grey
Safe
Beneish M-Score -2.1
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 47.97
9-Day RSI 38.46
14-Day RSI 33.88
6-1 Month Momentum % -33.51
12-1 Month Momentum % -59.2

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.8
Quick Ratio 3.53
Cash Ratio 2.7
Days Inventory 72.3
Days Sales Outstanding 80.45
Days Payable 154.53

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13.6

Financials (Next Earnings Date:2022-08-12 Est.)

CASI's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:CASI

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 33.494
EPS (TTM) ($) -0.22
Beta -0.02
Volatility % 68.51
14-Day RSI 33.88
14-Day ATR ($) 0.044652
20-Day SMA ($) 0.414487
12-1 Month Momentum % -59.2
52-Week Range ($) 0.3101 - 1.775
Shares Outstanding (Mil) 136.06

Piotroski F-Score Details

Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

CASI Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More